|
|
|
|
| Symbol(s): |
DEPO |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
DepoMed has a current Overall Rating of C (Neutral). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| DepoMed has a current Overall Rating of C (Neutral). Power Rating (57) is neutral; appreciation potential (10) is negative. Relative to the S&P 500 Composite, DepoMed Inc has both Growth and Value characteristics -- its appeal is likely to be to Capital Gain-oriented investors. DEPO is of high investment quality. DepoMed's current technical position is mixed. DepoMed's Power Rating is 57. The recent trend in DEPO's earnings estimates has been extremely favorable. DepoMed's...
| | |
|
|
